Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: A 2-week, multicenter, randomized, open-label study

Abstract Background: The National Heart, Lung, and Blood Institute guideline recommends that dosing racemic albuterol be administered every 1 to 4 hours for treating patients with asthma or chronic obstructive pulmonary disease (COPD) in the hospital. Previously published preliminary and retrospecti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2008, Vol.30, p.989-1002
Hauptverfasser:	Donohue, James F., MD, Hanania, Nicola A., MD, Ciubotaru, Ronald L., MD, Noe, Les, MPA, Pasta, David J., MS, Schaefer, Kendyl, MSc, Claus, Raymond, MS, Andrews, William T., MD, Roach, James, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Aged Albuterol - chemistry Albuterol - economics Albuterol - therapeutic use Asthma Asthma - drug therapy bronchoconstriction Bronchodilator Agents - chemistry Bronchodilator Agents - economics Bronchodilator Agents - therapeutic use Chronic obstructive pulmonary disease COPD Cost analysis costs Drug dosages Female Health care Heart failure Hospital Costs Hospitalization Humans Internal Medicine Length of Stay levalbuterol Male Medical Education Medicine Middle Aged Pediatrics Prospective Studies Pulmonary Disease, Chronic Obstructive - drug therapy racemic albuterol Respiratory Function Tests Severity of Illness Index Smooth muscle Stereoisomerism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!